Enzon Pharmaceuticals Stock Annual Yield
Enzon Pharmaceuticals fundamentals help investors to digest information that contributes to Enzon Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Enzon OTC Stock. The fundamental analysis module provides a way to measure Enzon Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Enzon Pharmaceuticals otc stock.
Enzon |
Enzon Pharmaceuticals OTC Stock Annual Yield Analysis
Enzon Pharmaceuticals' Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Current Enzon Pharmaceuticals Annual Yield | 0.65 % |
Most of Enzon Pharmaceuticals' fundamental indicators, such as Annual Yield, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Enzon Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
CompetitionIn accordance with the recently published financial statements, Enzon Pharmaceuticals has an Annual Yield of 0.648%. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The annual yield for all United States stocks is notably lower than that of the firm.
Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
All Next | Launch Module |
Enzon Fundamentals
Return On Equity | -0.016 | ||||
Return On Asset | -0.0138 | ||||
Operating Margin | (36.28) % | ||||
Current Valuation | 17.63 M | ||||
Shares Outstanding | 74.21 M | ||||
Shares Owned By Insiders | 10.70 % | ||||
Shares Owned By Institutions | 48.58 % | ||||
Number Of Shares Shorted | 259.38 K | ||||
Price To Earning | 1.52 X | ||||
Price To Book | 7.41 X | ||||
Price To Sales | 669.36 X | ||||
Revenue | 701 K | ||||
Gross Profit | 701 K | ||||
EBITDA | (469 K) | ||||
Net Income | (469 K) | ||||
Cash And Equivalents | 46.79 M | ||||
Cash Per Share | 0.63 X | ||||
Debt To Equity | 1.46 % | ||||
Current Ratio | 125.26 X | ||||
Book Value Per Share | 0.04 X | ||||
Cash Flow From Operations | (501 K) | ||||
Short Ratio | 1.71 X | ||||
Earnings Per Share | (0.04) X | ||||
Target Price | 14.0 | ||||
Beta | 0.17 | ||||
Market Capitalization | 19.72 M | ||||
Total Asset | 47.75 M | ||||
Retained Earnings | (75.61 M) | ||||
Working Capital | 6.98 M | ||||
Current Asset | 11.78 M | ||||
Current Liabilities | 4.8 M | ||||
Z Score | -1.4 | ||||
Annual Yield | 0.65 % | ||||
Net Asset | 47.75 M |
Pair Trading with Enzon Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Enzon Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzon Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Estee Lauder could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Estee Lauder when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Estee Lauder - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Estee Lauder Companies to buy it.
The correlation of Estee Lauder is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Estee Lauder moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Estee Lauder Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Estee Lauder can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation. Note that the Enzon Pharmaceuticals information on this page should be used as a complementary analysis to other Enzon Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Enzon OTC Stock
If you are still planning to invest in Enzon Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enzon Pharmaceuticals' history and understand the potential risks before investing.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |